All Topics
All Topics
Technology
Technology
AI
AI
Business
Business
Entertainment
Entertainment
News
News
Programming
Programming
Science
Science
Design
Design
Environment
Environment
Finance
Finance
Crypto
Crypto
Politics
Politics
Sports
Sports
Education
Education
Gaming
Gaming
Art
Art
Music
Music
Health
Health
Security
Security
Books
Books
Food
Food
Travel
Travel
Personal
Personal
Bluesky
Twitter

7-Minute Cancer Shot Launched in India: Cost, Benefits & What Patients Need to Know

India has recently introduced a new injectable immunotherapy treatment for lung cancer that can be given in just seven minutes. Unlike traditional intravenous (IV) immunotherapy, which may take hours…

Read the full article

You might also wanna read

Nature Medicine retracts study claiming morning immunotherapy improves lung cancer outcomes

Investigation finds problems in a key clinical trial that critics said was too good to be true

science.org·21d ago

Immunotherapy Shifts Treatment Paradigm for Hard-to-Cure Small Cell Lung Cancer

Immunotherapy is transforming treatment for small cell lung cancer, a hard-to-cure disease, cutting recurrence and death risk by 30% and ext

Seoul Economic Daily·6d ago

Triple-action cancer jab amivantamab shrinks tumors in over a third of patients in international trial

Jab brought ‘unprecedentedly strong responses’ in patients whose disease had become resistant to chemotherapy and immunotherapy

theguardian.com·1mo ago

Common medication for lung cancer symptoms found to limit effectiveness of cancer treatment

LOS ANGELES — Corticosteroids, a commonly prescribed medication to alleviate cancer-related symptoms for non-small cell lung cancer patients

Keck Medicine of USC·1y ago

Lung transplants extend lives of sickest cancer patients better than standard treatment: study

Patients with advanced lung cancer are far more likely to survive if they receive a lung transplant compared to patients who received a stan

Chicago Sun-Times·8d ago

A Multicenter Randomized Open-Label Trial Evaluating MRD-Guided Interruption Versus Standard of Care Immune-Checkpoint Inhibitor (ICI) Therapy In Patients With Advanced / Metastatic Solid Tumors.

Conditions : NSCLC (Advanced Non-small Cell Lung Cancer); NSCLC (Non-small Cell Lung Cancer); NSCLC (Non-small Cell Lung Carcinoma); NSCLC;

clinicaltrials.gov·9d ago

Comments

Sign in to join the conversation.

No comments yet. Be the first.